Tumor Ablation and Immunotherapy: Emerging Potential
Tumor Ablation and Immunotherapy: Emerging Potential Kings Research
Онкология
Иммунотерапия и CAR-T
185 материалов по теме, собраны автоматически из проверенных источников
Онкология
Researchers identify key pathway that drives T-cell exhaustion in cancer immunotherapy
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, limiting their ability to keep tumors under control.
Онкология
От эксперимента к практике: как CAR-T терапия приближается к лечению солидных опухолей
От эксперимента к практике: как CAR-T терапия приближается к лечению солидных опухолей Наука Mail
Онкология
Immunotherapy Before Standard Treatment Shows Striking Results in Nasopharyngeal Cancer
Immunotherapy Before Standard Treatment Shows Striking Results in Nasopharyngeal Cancer Bioengineer.org
Онкология
Reversible genetic switches could give cancer immunotherapy more precise control
A genetic switch that activates immune cells as they fight tumors: this is the new strategy developed by an international research team coordinated by Velia Siciliano at the Istituto Italiano di Tecnologia (IIT—Italian Institute of Technology) in Naples and described in the journal Nature Communications. The study…
Онкология
FDA expands Anktiva approval for bladder cancer
The FDA expanded the approval of a first-in-class immunotherapy to include a new subgroup of people with bladder cancer. Nogapendekin alfa inbakicept-pmln (Anktiva, Altor BioScience LLC/ImmunityBio) is now indicated for use with Bacillus Calmette-Guérin (BCG) for adults with high-grade papillary-only bladder cancer…
Онкология
FDA approves immunotherapy regimen studied by Mayo Clinic
FDA approves immunotherapy regimen studied by Mayo Clinic Your Valley
Онкология
Scientists Identify Clues to Making Immunotherapy More Effective Against Glioblastoma | Newswise
Scientists Identify Clues to Making Immunotherapy More Effective Against Glioblastoma | Newswise Newswise
Онкология
Scientists identify clues to making immunotherapy more effective against glioblastoma
Two new studies led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center provide new insight into how the immune system can successfully be activated against glioblastoma while revealing why these therapies have historically fallen short.
Онкология
BioNTech Shares Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy in Metastatic HPV16-Positive HNC
BioNTech Shares Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy in Metastatic HPV16-Positive HNC Oncodaily
Онкология
BioNTech mRNA cancer immunotherapy misses first objective in key study
BioNTech mRNA cancer immunotherapy misses first objective in key study BioPharma Dive
Онкология
BioNTech mRNA cancer immunotherapy misses first objective in key study
BioNTech mRNA cancer immunotherapy misses first objective in key study Yahoo Finance
Онкология
Phase 1b/2 HERBOT Trial: First-Line HER2-Targeted Chemoimmunotherapy in Biliary Tract Cancer
Phase 1b/2 HERBOT Trial: First-Line HER2-Targeted Chemoimmunotherapy in Biliary Tract Cancer Oncodaily
Онкология
BioNTech (BNTX) announced that the AHEAD-MERIT Phase 2/3 clinical trial did not meet its first dual primary endpoint of progression-free survival for the mRNA cancer immunotherapy candidate BNT113 plus pembrolizumab compared with pembrolizumab al
BioNTech (BNTX) announced that the AHEAD-MERIT Phase 2/3 clinical trial did not meet its first dual primary endpoint of progression-free survival for the mRNA cancer immunotherapy candidate BNT113 plus pembrolizumab compared with pembrolizumab al Newsquawk
Онкология
BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer
BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer The Manila Times